Cytochrome P450 genes expression in human prostate cancer
- PMID: 38469085
- PMCID: PMC10926225
- DOI: 10.1016/j.ymgmr.2024.101049
Cytochrome P450 genes expression in human prostate cancer
Abstract
CYP-dependent metabolites play a critical role in regulating the cell cycle, as well as the proliferative, invasive, and migratory activity of cancer cells. We conducted a study to analyze the relative gene expression of various CYPs (CYP7B1, CYP27A1, CYP39A1, CYP51, CYP1B1, CYP3A5, CYP4F8, CYP5A1, CYP4F2, CYP2J2, CYP2E1, CYP2R1, CYP27B1, CYP24A1) in 41 pairs of prostate samples (tumor and conventional normal tissues) using qPCR. Our analysis determined significant individual variability in the expression levels of all studied CYPs, both in the tumor and in conventionally normal groups. However, when we performed a paired test between the tumor and normal groups, we found no significant difference in the expression of the studied genes. We did observe a tendency to increase the level of CYP1B1 expression in the tumor group. We also did not find any significant difference between the levels of the studied CYPs in the tumor and conventional normal groups at different stages of prostate cancer and pathomorphological indicators. Correlation analysis revealed the presence of a positive relationship between the expressions of some cholesterol-metabolizing CYP genes, as well as between genes responsible for vitamin D biosynthesis and cholesterol biosynthesis. We observed significant correlative relationships between the expression of CYPs and some prostate cancer-related genes (CDH2, MMP9, SCHLAP1, GCR, CYP17A1, ACTA2, CXCL14, FAP, CCL17, MSMB, IRF1, VDR). Therefore, the expression of CYPs is not directly associated with prostate cancer but is largely determined by genetic, epigenetic factors, as well as endogenous substrates and xenobiotics. The significant correlative relationship between CYPs and genes associated with cancer may indicate common regulatory pathways that may have a synergistic effect on the tumor, ensuring the survival of cancer cells.
Keywords: CYPs; Cytochrome P450; Prostate cancer.
© 2024 The Authors. Published by Elsevier Inc.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Altered expression of cytochrome P450 enzymes involved in metabolism of androgens and vitamin D in the prostate as a risk factor for prostate cancer.Pharmacol Rep. 2020 Oct;72(5):1161-1172. doi: 10.1007/s43440-020-00133-y. Epub 2020 Jul 17. Pharmacol Rep. 2020. PMID: 32681429 Review.
-
Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma.Int J Oncol. 2005 Sep;27(3):661-7. Int J Oncol. 2005. PMID: 16077914
-
A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis.Breast Cancer Res Treat. 2003 Dec;82(3):191-7. doi: 10.1023/B:BREA.0000004376.21491.44. Breast Cancer Res Treat. 2003. PMID: 14703066
-
The roles of cytochrome P450 enzymes in prostate cancer development and treatment.Anticancer Res. 2012 Jan;32(1):291-8. Anticancer Res. 2012. PMID: 22213318 Review.
-
Differential expression of cytochrome P450 enzymes in normal and tumor tissues from childhood rhabdomyosarcoma.PLoS One. 2014 Apr 3;9(4):e93261. doi: 10.1371/journal.pone.0093261. eCollection 2014. PLoS One. 2014. PMID: 24699256 Free PMC article.
Cited by
-
CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients-Diamond Study).Int J Mol Sci. 2024 Apr 27;25(9):4762. doi: 10.3390/ijms25094762. Int J Mol Sci. 2024. PMID: 38731981 Free PMC article.
-
Endocrine-disrupting chemicals as prostate carcinogens.Nat Rev Urol. 2025 Sep;22(9):609-631. doi: 10.1038/s41585-025-01031-9. Epub 2025 May 16. Nat Rev Urol. 2025. PMID: 40379948 Review.
-
Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments.Cancer Rep (Hoboken). 2024 Oct;7(10):e70016. doi: 10.1002/cnr2.70016. Cancer Rep (Hoboken). 2024. PMID: 39410867 Free PMC article. Review.
-
Differential gene expression analysis supports dysregulation of mitochondrial activity as a new perspective for glioblastoma's aggressiveness.Heliyon. 2024 Nov 15;10(22):e40414. doi: 10.1016/j.heliyon.2024.e40414. eCollection 2024 Nov 30. Heliyon. 2024. PMID: 39641080 Free PMC article.
-
Mechanism of Action and Interaction of Garlic Extract and Established Therapeutics in Prostate Cancer.Int J Mol Sci. 2025 Feb 19;26(4):1777. doi: 10.3390/ijms26041777. Int J Mol Sci. 2025. PMID: 40004239 Free PMC article.
References
-
- Chen T.C., Sakaki T., Yamamoto K., Kittaka A. The roles of cytochrome P450 enzymes in prostate cancer development and treatment. Anticancer Res. 2012;32:291–298. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous